Arkolith/Insider Trading/CMXC/Form 4

Hargreaves Bradley S

VP Technology & Operations, Director, 10% OwnerCell MedX Corp. (CMXC) · full profile →Form 4 · filed Feb 11, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$54
Net Open-Market Flow
-$54
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 7, 2022Sell(S)300$0.18$545.5M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001626659-22-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML